BIOCOM raises Series A funding to enhance AI-powered healthcare solutions, securing investment from NH Bank, Nice Investment Partners, and Shinhan Venture Investment.
Round Type
Series A
Gangseo-guHealth CareArtificial IntelligenceInvestors
Description
BIOCOM, a Korean AI healthcare startup, has secured Series A funding from NH Bank, Nice Investment Partners, and Shinhan Venture Investment. The funding will accelerate the development of its AI Behavioral Change Coaching Agent, set for launch in 2026. BIOCOM's solutions leverage AI on multi-omics data to provide personalized health management. The company achieved 2.2x revenue growth in 2025 while establishing its direct-to-consumer platform.
Quick answer
BIOCOM raised an undisclosed amount in a Series A round, dated December 29, 2025. Investors: Shinhan Venture Investment, Nice Investment Partners and NH Bank. BIOCOM is based in Gangseo-gu, Seoul, South Korea.
- How much did BIOCOM raise?
- BIOCOM raised an undisclosed amount in a Series A round on December 29, 2025.
- Who invested in BIOCOM?
- Shinhan Venture Investment, Nice Investment Partners and NH Bank are named as investors in this round.
- What does BIOCOM do?
- BIOCOM is a Korean AI healthcare startup that harnesses the power of AI to provide personalized optimal health management solutions.
- Where is BIOCOM based and how big is it?
- BIOCOM is based in Gangseo-gu, Seoul, South Korea.
- Who are the decision-makers at BIOCOM?
- Fundz holds 1 contact at BIOCOM. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Care and Artificial Intelligence around the same time
Companies in the same sectors as BIOCOM that raised within 45 days of this round, from Fundz verified event records.
- Crink raised $198K (Pre-Seed) on February 11, 2026.
- Take2 raised $14M (Series A) on February 11, 2026.
- DentalMonitoring raised $100M (Funding Round) on February 10, 2026.
- Dawn Health raised $26M on February 10, 2026.
- Lantern raised $1.1M (Seed) on February 9, 2026.
- Gardia raised $10M (Series A) on February 6, 2026.
Who to call at BIOCOM, and when
A new round usually means BIOCOM is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BIOCOM raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BIOCOM, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BIOCOM. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BIOCOM raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBIOCOM raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.